🇺🇸 FDA
Company

ENANTA

ENANTA PHARMACEUTICALS INC

ENTA pharma USA

Quick answer

ENANTA is a pharma company (ENTA) headquartered in WATERTOWN, MA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

EDP-235

COVID-19

Phase 2 · small_molecule · completed

3 trials project

EDP-305 1 mg

Primary Biliary Cholangitis

Phase 2 · small_molecule · completed

1 trials project

EDP-305 1.5 mg

Non-Alcoholic Steatohepatitis

Phase 2 · small_molecule · terminated

1 trials project

EDP-305 Dose 1

Non-Alcoholic Steatohepatitis

Phase 2 · small_molecule · completed

1 trials project

EDP-323 Dose Regimen 1

RSV Infection

Phase 2 · small_molecule · completed

1 trials project

EDP-420 / Duration of Treatment - 3 days

Community Acquired Pneumonia

Phase 2 · small_molecule · active

1 trials project

EDP-938

Respiratory Syncytial Virus (RSV)

Phase 2 · small_molecule · completed

2 trials project

EDP-938

Respiratory Syncytial Virus

Phase 2 · small_molecule · completed

1 trials project

EDP-938

RSV Infection

Phase 2 · small_molecule · completed

6 trials project

EDP-938

Respiratory Syncytial Virus Infections

Phase 2 · small_molecule · terminated

1 trials project

EDP-938 Dose 1

RSV Infection

Phase 2 · small_molecule · completed

1 trials project

zelicapavir

RSV Infection

Phase 2 · small_molecule · active

1 trials project

DEB025

Hepatitis C Virus

Phase 1 · small_molecule · completed

1 trials project

EDP 305

NASH

Phase 1 · small_molecule · completed

1 trials project

EDP 305

Presumptive NAFLD

Phase 1 · small_molecule · completed

1 trials project

EDP-235

SARS CoV 2 Infection

Phase 1 · small_molecule · completed

1 trials project

EDP-297

NASH - Nonalcoholic Steatohepatitis With Liver Fibrosis

Phase 1 · small_molecule · completed

1 trials project

EDP-305

NASH - Nonalcoholic Steatohepatitis

Phase 1 · small_molecule · completed

2 trials project

EDP-322

MRSA, SSTI

Phase 1 · small_molecule · completed

1 trials project

EDP-322

Skin and Soft Tissue Infections

Phase 1 · small_molecule · completed

1 trials project

EDP-323

RSV Infection

Phase 1 · small_molecule · completed

3 trials project

EDP-494

Hepatitis C

Phase 1 · small_molecule · completed

1 trials project

EDP-514

Chronic HBV Infection

Phase 1 · small_molecule · completed

2 trials project

EDP-514

Hepatitis B

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12384753

17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use there

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12358921

Antiviral heterocyclic compounds

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12297209

Benzodiazepine derivatives as RSV inhibitors

Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12281140

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12268694

Combination pharmaceutical agents as RSV inhibitors

Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12264159

Functionalized heterocycles as antiviral agents

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12162857

Antiviral compounds

Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12145941

Heterocyclic antiviral agents

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)